---
title: "Vigil Neuroscience (VIGL.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/VIGL.US.md"
symbol: "VIGL.US"
name: "Vigil Neuroscience"
industry: "Biotechnology"
---

# Vigil Neuroscience (VIGL.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States. The company’s lead candidate is VGL101(Iluzanebart),...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.17 | 409/605 | - | - | - |
| PB | 9.31 | 409/605 | 9.31 | 9.31 | 1.37 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.05 |

## References

- [Company Overview](https://longbridge.com/en/quote/VIGL.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/VIGL.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/VIGL.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.